Related Experiment Video
Updated: May 12, 2025
Pre-Chiasmatic, Single Injection of Autologous Blood to Induce Experimental Subarachnoid Hemorrhage in a Rat Model
Published on: June 18, 2021
Rituximab in the Treatment of Subarachnoid Hemorrhage and Widespread Bleeding in Microscopic Polyangiitis : A Case
Tian Tao1, Lizeyu Lv1,2, Jun Chen3
1Department of Nephrology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Abstract:
Microscopic polyangiitis (MPA) is a rare autoimmune disorder characterized by small-vessel vasculitis and the presence of anti-neutrophil cytoplasmic antibody (ANCA). Typically, MPA primarily affects the respiratory system, kidneys, and skin, with infrequent involvement of the nervous system, resulting in neuropathy. However, the occurrence of subarachnoid hemorrhage (SAH) in MPA is exceedingly rare, especially when it is accompanied by hemorrhagic events in multiple organs. This case report details the clinical presentation of a 61-yearold male patient diagnosed with MPA who experienced an exceptionally uncommon occurrence of SAH, coupled with extensive bleeding manifestations including epistaxis, skin purpura, and gastrointestinal bleeding. Notably, the patient's symptoms exhibited potential improvement following a treatment regimen consisting of rituximab and glucocorticoids. This case emphasizes the critical importance of promptly recognizing and comprehensively managing rare complications in MPA patients to optimize clinical outcomes.
Insights
Microscopic polyangiitis (MPA), a rare autoimmune disease, can present with unusual bleeding complications like subarachnoid hemorrhage (SAH). Early recognition and management of these rare MPA manifestations are crucial for patient outcomes.
Area of Science:
- Rheumatology
- Neurology
- Nephrology
Background:
- Microscopic polyangiitis (MPA) is a rare autoimmune vasculitis associated with anti-neutrophil cytoplasmic antibodies (ANCA).
- MPA typically affects the respiratory system, kidneys, and skin, with rare neurological involvement like neuropathy.
Observation:
- This case report describes a 61-year-old male with MPA presenting with subarachnoid hemorrhage (SAH).
- The patient also exhibited extensive bleeding, including epistaxis, skin purpura, and gastrointestinal bleeding.
Findings:
- The co-occurrence of SAH and widespread hemorrhagic events in MPA is exceedingly rare.
- Treatment with rituximab and glucocorticoids showed potential improvement in the patient's symptoms.
Implications:
- This case highlights the importance of considering rare neurological and hemorrhagic complications in MPA diagnosis.
- Prompt recognition and comprehensive management are vital for optimizing clinical outcomes in patients with MPA.
More Related Videos
11:20Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases
Published on: June 14, 2021
07:25In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
Published on: May 4, 2017
Related Concept Videos
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents